Avidity Biosciences
RNAM
#1786
Rank
โ‚ฌ10.25 B
Marketcap
66,38ย โ‚ฌ
Share price
0.00%
Change (1 day)
52.04%
Change (1 year)

Earnings for Avidity Biosciences (RNAM)

Earnings in 2025 (TTM): -โ‚ฌ0.6 Billion

According to Avidity Biosciences's latest financial reports the company's current earnings are โ‚ฌ18.75 Million. a decrease over its 2024 earnings that were of -โ‚ฌ0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avidity Biosciences from 2019 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚ฌ0.63 Billion112.42%
2024 -โ‚ฌ0.3 Billion51.87%
2023 -โ‚ฌ0.2 Billion21.97%
2022 -โ‚ฌ0.16 Billion47.44%
2021 -โ‚ฌ0.11 Billion166.06%
2020 -โ‚ฌ40.44 Million79.33%
2019 -โ‚ฌ22.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.35 B-1,117.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ6.52 B-1,145.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚ฌ0.12 Billion-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚ฌ77.57 Million-87.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚ฌ0.13 Billion-80.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚ฌ0.25 Billion-60.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚ฌ0.24 Billion-62.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.27 B-143.30%๐Ÿ‡บ๐Ÿ‡ธ USA